Nα-Z-Nin-Boc-L-tryptophan dicylohexylammonium salt
Need Assistance?
  • US & Canada:
    +
  • UK: +

Nα-Z-Nin-Boc-L-tryptophan dicylohexylammonium salt

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
BOC-Amino Acids
Catalog number
BAT-004304
CAS number
218938-57-9
Molecular Formula
C24H26N2O6·C12H23N
Molecular Weight
619.80
Nα-Z-Nin-Boc-L-tryptophan dicylohexylammonium salt
IUPAC Name
N-cyclohexylcyclohexanamine;(2S)-3-[1-[(2-methylpropan-2-yl)oxycarbonyl]indol-3-yl]-2-(phenylmethoxycarbonylamino)propanoic acid
Synonyms
Z-L-Trp(Boc)-OH DCHA; 1-Boc-Nalpha-Cbz-L-Tryptophan Dicyclohexylamine Salt
Appearance
White to off-white powder
Purity
≥ 99.5% (Chiral HPLC)
Melting Point
147-152 °C
Boiling Point
772.4°C
Storage
Store at 2-8 °C
InChI
InChI=1S/C24H26N2O6.C12H23N/c1-24(2,3)32-23(30)26-14-17(18-11-7-8-12-20(18)26)13-19(21(27)28)25-22(29)31-15-16-9-5-4-6-10-16;1-3-7-11(8-4-1)13-12-9-5-2-6-10-12/h4-12,14,19H,13,15H2,1-3H3,(H,25,29)(H,27,28);11-13H,1-10H2/t19-;/m0./s1
InChI Key
BUQVAJPBCWSLMH-FYZYNONXSA-N
Canonical SMILES
CC(C)(C)OC(=O)N1C=C(C2=CC=CC=C21)CC(C(=O)O)NC(=O)OCC3=CC=CC=C3.C1CCC(CC1)NC2CCCCC2
2. Salt and hypertension: is salt dietary reduction worth the effort?
Tiberio M Frisoli, Roland E Schmieder, Tomasz Grodzicki, Franz H Messerli Am J Med. 2012 May;125(5):433-9. doi: 10.1016/j.amjmed.2011.10.023.
In numerous epidemiologic, clinical, and experimental studies, dietary sodium intake has been linked to blood pressure, and a reduction in dietary salt intake has been documented to lower blood pressure. In young subjects, salt intake has a programming effect in that blood pressure remains elevated even after a high salt intake has been reduced. Elderly subjects, African Americans, and obese patients are more sensitive to the blood pressure-lowering effects of a decreased salt intake. Depending on the baseline blood pressure and degree of salt intake reduction, systolic blood pressure can be lowered by 4 to 8 mm Hg. A greater decrease in blood pressure is achieved when a reduced salt intake is combined with other lifestyle interventions, such as adherence to Dietary Approaches to Stop Hypertension. A high salt intake has been shown to increase not only blood pressure but also the risk of stroke, left ventricular hypertrophy, and proteinuria. Adverse effects associated with salt intake reduction, unless excessive, seem to be minimal. However, data linking a decreased salt intake to a decrease in morbidity and mortality in hypertensive patients are not unanimous. Dietary salt intake reduction can delay or prevent the incidence of antihypertensive therapy, can facilitate blood pressure reduction in hypertensive patients receiving medical therapy, and may represent a simple cost-saving mediator to reduce cardiovascular morbidity and mortality.
Online Inquiry
Verification code
Inquiry Basket